These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32047657)

  • 1. Novel mucosal adjuvant, mastoparan-7, improves cocaine vaccine efficacy.
    St John AL; Choi HW; Walker QD; Blough B; Kuhn CM; Abraham SN; Staats HF
    NPJ Vaccines; 2020; 5(1):12. PubMed ID: 32047657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a broadly active influenza intranasal vaccine adjuvanted with self-assembled particles composed of mastoparan-7 and CpG.
    Ontiveros-Padilla L; Batty CJ; Hendy DA; Pena ES; Roque JA; Stiepel RT; Carlock MA; Simpson SR; Ross TM; Abraham SN; Staats HF; Bachelder EM; Ainslie KM
    Front Immunol; 2023; 14():1103765. PubMed ID: 37033992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyphosphazene: A New Adjuvant Platform for Cocaine Vaccine Development.
    Lin M; Marin A; Ellis B; Eubanks LM; Andrianov AK; Janda KD
    Mol Pharm; 2022 Sep; 19(9):3358-3366. PubMed ID: 35984034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal Immunization With Small Molecule Mast Cell Activators Enhance Immunity to Co-Administered Subunit Immunogens.
    Johnson-Weaver BT; Choi HW; Yang H; Granek JA; Chan C; Abraham SN; Staats HF
    Front Immunol; 2021; 12():730346. PubMed ID: 34566991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immunization with an adenoviral vector vaccine confers superior protection against RSV compared to natural immunity.
    Maier C; Fuchs J; Irrgang P; Wißing MH; Beyerlein J; Tenbusch M; Lapuente D
    Front Immunol; 2022; 13():920256. PubMed ID: 36003372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal Vaccination With Recombinant
    Wei J; Hegde VL; Yanamandra AV; O'Hara MP; Keegan B; Jones KM; Strych U; Bottazzi ME; Zhan B; Sastry KJ; Hotez PJ
    Front Immunol; 2022; 13():800295. PubMed ID: 35197976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against cocaine using a modifiable dendrimer nanoparticle platform.
    Lowell JA; Dikici E; Joshi PM; Landgraf R; Lemmon VP; Daunert S; Izenwasser S; Daftarian P
    Vaccine; 2020 Nov; 38(50):7989-7997. PubMed ID: 33158592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic Anti-Cocaine Nanoaccine Successfully Prevents Cocaine-Induced Hyperlocomotion.
    Madge HYR; Alexander S; Azuar A; Zhang J; Koirala P; Burne TH; Toth I; Stephenson RJ
    J Med Chem; 2023 Sep; 66(17):12407-12419. PubMed ID: 37646732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers.
    Jalah R; Torres OB; Mayorov AV; Li F; Antoline JF; Jacobson AE; Rice KC; Deschamps JR; Beck Z; Alving CR; Matyas GR
    Bioconjug Chem; 2015 Jun; 26(6):1041-53. PubMed ID: 25970207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the effects of hapten stability on cocaine vaccine immunogenicity.
    Cai X; Whitfield T; Moreno AY; Grant Y; Hixon MS; Koob GF; Janda KD
    Mol Pharm; 2013 Nov; 10(11):4176-84. PubMed ID: 23927436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge.
    Kwa S; Lai L; Gangadhara S; Siddiqui M; Pillai VB; Labranche C; Yu T; Moss B; Montefiori DC; Robinson HL; Kozlowski PA; Amara RR
    J Virol; 2014 Sep; 88(17):9579-89. PubMed ID: 24920805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocaine Vaccine Development: Evaluation of Carrier and Adjuvant Combinations That Activate Multiple Toll-Like Receptors.
    Kimishima A; Wenthur CJ; Eubanks LM; Sato S; Janda KD
    Mol Pharm; 2016 Nov; 13(11):3884-3890. PubMed ID: 27717287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing active cocaine vaccination performance through catalytic and noncatalytic hapten design.
    Cai X; Whitfield T; Hixon MS; Grant Y; Koob GF; Janda KD
    J Med Chem; 2013 May; 56(9):3701-9. PubMed ID: 23627877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs.
    Matyas GR; Mayorov AV; Rice KC; Jacobson AE; Cheng K; Iyer MR; Li F; Beck Z; Janda KD; Alving CR
    Vaccine; 2013 Jun; 31(26):2804-10. PubMed ID: 23624097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.
    Khalil SM; Tonkin DR; Snead AT; Parks GD; Johnston RE; White LJ
    J Virol; 2014 Aug; 88(16):9182-96. PubMed ID: 24899195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flagellin as carrier and adjuvant in cocaine vaccine development.
    Lockner JW; Eubanks LM; Choi JL; Lively JM; Schlosburg JE; Collins KC; Globisch D; Rosenfeld-Gunn RJ; Wilson IA; Janda KD
    Mol Pharm; 2015 Feb; 12(2):653-62. PubMed ID: 25531528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of enhanced antibody response toward dual delivery of nano-adjuvant adsorbed human Enterovirus-71 vaccine encapsulated carrier.
    Saeed MI; Omar AR; Hussein MZ; Elkhidir IM; Sekawi Z
    Hum Vaccin Immunother; 2015; 11(10):2414-24. PubMed ID: 26186664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized Mucosal Modified Vaccinia Virus Ankara Prime/Soluble gp120 Boost HIV Vaccination Regimen Induces Antibody Responses Similar to Those of an Intramuscular Regimen.
    Jones DI; Pollara JJ; Johnson-Weaver BT; LaBranche CC; Montefiori DC; Pickup DJ; Permar SR; Abraham SN; Maddaloni M; Pascual DW; Staats HF
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31068425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hapten optimization for cocaine vaccine with improved cocaine recognition.
    Ramakrishnan M; Kinsey BM; Singh RA; Kosten TR; Orson FM
    Chem Biol Drug Des; 2014 Sep; 84(3):354-63. PubMed ID: 24803171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of cholera toxin B as a mucosal adjuvant elicits antibody-mediated protection against
    Wiedinger K; Pinho D; Bitsaktsis C
    Ther Adv Vaccines; 2017 Feb; 5(1):15-24. PubMed ID: 28344805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.